LMWHs also inhibit CXCR4 in breast cancer mouse models [51], while CXCR4 inhibition also mitigates desmoplasia and enhances T cell infiltration, rendering metastatic breast cancer more susceptible to immunotherapy [52]. Here, CXCR4 is linked to breast carcinoma.